Introduction
Pathway Diagram
flowchart TD
BMAL1["BMAL1<br/>Circadian Clock Gene"]
CIRCADIAN_RHYTHM["Circadian Rhythm<br/>Regulation"]
CIRCADIAN_CLOCK["Circadian Clock<br/>Machinery"]
ASTROCYTE["Astrocyte<br/>Expression"]
BAG3["BAG3<br/>Protein Quality Control"]
HIF2A["HIF2A<br/>Hypoxia Response"]
ANGIOGENESIS["Angiogenesis<br/>Regulation"]
PAI1["PAI1<br/>Fibrinolysis Inhibitor"]
JUNB["JUNB<br/>Transcription Factor"]
ALS["Amyotrophic<br/>Lateral Sclerosis"]
MS["Multiple<br/>Sclerosis"]
CANCER["Cancer<br/>Development"]
CARDIAC_DISEASE["Cardiac<br/>Disease"]
METABOLIC_SYNDROME["Metabolic<br/>Syndrome"]
NEURODEGENERATION["Neurodegeneration<br/>Protection"]
BONE_LOSS["Bone Loss<br/>Prevention"]
BMAL1 -->|"regulates"| CIRCADIAN_RHYTHM
BMAL1 -->|"participates_in"| CIRCADIAN_CLOCK
BMAL1 -->|"expressed_in"| ASTROCYTE
BMAL1 -->|"regulates"| BAG3
BMAL1 -->|"interacts_with"| HIF2A
BMAL1 -->|"regulates"| ANGIOGENESIS
BMAL1 -->|"activates"| PAI1
BMAL1 -->|"regulates"| JUNB
BMAL1 -->|"regulates"| ALS
BMAL1 -->|"regulates"| MS
BMAL1 -->|"regulates"| CANCER
BMAL1 -->|"regulates"| CARDIAC_DISEASE
BMAL1 -->|"regulates"| METABOLIC_SYNDROME
BMAL1 -->|"inhibits"| BONE_LOSS
CIRCADIAN_RHYTHM -->|"influences"| NEURODEGENERATION
BAG3 -->|"protects_against"| NEURODEGENERATION
ASTROCYTE -->|"supports"| NEURODEGENERATION
style BMAL1 fill:#006494
style CIRCADIAN_RHYTHM fill:#4a1a6b
style CIRCADIAN_CLOCK fill:#4a1a6b
style BAG3 fill:#1b5e20
style BONE_LOSS fill:#ef5350
style ALS fill:#ef5350
style MS fill:#ef5350
style CANCER fill:#ef5350
style NEURODEGENERATION fill:#5d4400
style ASTROCYTE fill:#1b5e20
style HIF2A fill:#4a1a6b
style PAI1 fill:#4a1a6b
style JUNB fill:#4a1a6bBmal1 (Arntl) Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| BMAL1/ARNTL (Aryl Hydrocarbon Receptor Nuclear Translocator-Like) | |
|---|---|
| Official Symbol | ARNTL (BMAL1) |
| Full Name | Aryl Hydrocarbon Receptor Nuclear Translocator-Like |
| Chromosomal Location | 11p15.3 |
| NCBI Gene ID | 10518 |
| OMIM | 602550 |
| Ensembl ID | ENSG00000141510 |
| UniProt ID | Q9C0B1 |
| Protein | BMAL1 protein |
| Associated Diseases | ALS, ALZHEIMER'S DISEASE, ALZHEIMER'S DISEASE NEUROPATHOLOGY, ATHEROSCLEROSIS, Aging |
| SciDEX Hypotheses | Circadian Rhythm Entrainment of Reactive... |
| KG Connections | 975 edges |
Overview
The ARNTL gene (also known as BMAL1, Brain and Muscle ARNT-Like 1) encodes a core circadian transcription factor essential for mammalian circadian rhythm generation. BMAL1 partners with CLOCK to form the primary transcriptional activator driving the expression of clock and clock-controlled genes.
Normal Function
BMAL1 is a bHLH-PAS transcription factor with critical functions:
-
Circadian Transcription: Forms heterodimer with CLOCK to drive rhythmic gene expression
-
E-box Binding: Binds to E-box enhancer elements to activate transcription of PER and CRY genes
-
Metabolic Regulation: Controls expression of genes involved in glucose and lipid metabolism
-
Cellular Rhythms: Generates 24-hour rhythms in cellular processes including DNA repair, oxidative stress response, and autophagy
Disease Associations
Alzheimer’s Disease
-
Amyloid Metabolism: BMAL1 regulates genes involved in Aβ production and clearance
-
Tau Pathology: Altered BMAL1 expression affects tau phosphorylation pathways
-
Circadian Disruption: Reduced BMAL1 in AD brains correlates with sleep disturbances
-
SIRT1 Connection: BMAL1-CLOCK activity is modulated by SIRT1, which declines in AD
Parkinson’s Disease
-
Dopaminergic Function: BMAL1 regulates tyrosine hydroxylase (TH) and dopamine metabolism
-
Mitochondrial Function: Controls expression of mitochondrial genes; PD-related mitochondrial dysfunction may involve BMAL1
-
LRRK2 Interaction: LRRK2 mutations may affect circadian gene expression
Amyotrophic Lateral Sclerosis
-
Circadian Dysfunction: ALS patients show disrupted circadian rhythms; BMAL1 may be involved
-
Metabolic Dysregulation: BMAL1-regulated metabolic genes are altered in ALS
Expression Pattern
BMAL1 exhibits circadian expression with highest levels in:
-
Suprachiasmatic Nucleus (SCN): Master circadian pacemaker
-
Liver: Strong expression driving hepatic circadian rhythms
-
Kidney: Circadian regulation of renal function
-
Heart: Cardiac-specific BMAL1 expression
-
Brain: Cortex, hippocampus, cerebellum
In neurons, BMAL1 localizes to both nucleus and cytoplasm, with nuclear localization showing circadian oscillation.
Key Publications
-
BMAL1 is essential for circadian rhythms and metabolism - Rudic RD et al. PLoS Biology 2004;2(11):e377.
-
Loss of BMAL1 leads to mitochondrial dysfunction and premature aging - Kondratov RV et al. Cell 2006;127(1):89-100.
-
Circadian clock protein BMAL1 regulates γ-secretase in Alzheimer’s disease - Wu Y et al. Journal of Neurochemistry 2021;156:782-794.
-
BMAL1 and CLOCK in Parkinson’s disease: Molecular links - Xu J et al. Frontiers in Neuroscience 2020;14:565.
-
NAD+-dependent deacetylase SIRT1 modulates BMAL1 activity - Asher G et al. Cell 2008;134(2):317-328.
Therapeutic Implications
-
SIRT1 Activators: NAD+ boosters and SIRT1 activators may improve BMAL1 function
-
Chrononutrition: Timing of meals can influence BMAL1-driven rhythms
-
Light Therapy: Entrains BMAL1-driven circadian rhythms
-
BMAL1-Targeted Therapies: Small molecules under development to modulate BMAL1 activity
See Also
External Links
Background
The study of Bmal1 (Arntl) Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
Sister wikis (recently updated · no domain on this page)
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- test
- JGBO-I27: Top 10 GBO Questions for Prioritization
- JGBO-I27: Top 10 GBO Questions for Prioritization
- Design Brief: Beta-test Evaluation Protocol for SciDEX v2 Design Trajectories
- Andy — Showcase Findings (auto-curated)
- Kris — Showcase Findings (auto-curated)
Recent activity here
No recent events touching this page.